FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to the field of medicine and pharmacology, namely to lithium beta-phenyl-gamma-aminobutyrate of the following formula, which can find application as a mood stabilizing agent.
.
EFFECT: technical result consists in expanding the assortment of mood stabilizing agent by obtaining a substance with a higher activity and lower toxicity.
1 cl, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| ANXIOLYTIC AND CEREBROPROTECTIVE AGENT REDUCING INCLINATION TO ALCOHOL | 2008 |
|
RU2393855C1 |
| DISODIUM SALT OF SALICYLURIC ACID, POSSESSING CEREBROPROTECTIVE ACTIVITY | 2014 |
|
RU2570644C1 |
| METHOD FOR IMPROVEMENT OF ANIMAL STRESS RESISTANCE | 2009 |
|
RU2402205C1 |
| AGENT ELICITING ANTI-ISCHEMIC, HYPOTENSIVE, ANTI- -ARRHYTHMIC AND NOOTROPIC ACTIVITY | 2002 |
|
RU2216322C1 |
| COMPLEX COMPOUND OF 5-AMINOSALICYLIC ACID WITH OXIDISED PECTIN, EXHIBITING ANTIULCER ACTIVITY, AND METHOD FOR PRODUCTION THEREOF | 2023 |
|
RU2818489C1 |
| 4-[(4-ACETOXYBENZOYL)AMINO]BUTYRATE OF LITHIUM, HAVING CEREBROPROTECTIVE ACTION | 2015 |
|
RU2617233C2 |
| POTASSIUM N-(4-ACETOXYBENZOYL)GLYCINATE POSSESSING CEREBROPROTECTIVE ACTIVITY | 2014 |
|
RU2556637C1 |
| STRESS-PROTECTIVE AGENT SHOWING ANTIAMNESTIC, ANTIHYPOXIC, ANXIOLYTIC AND ANTI-SHOCK-PRODUCING ACTIONS | 1992 |
|
RU2064793C1 |
| AGENT POSSESSING ENDOTHELIUM PROTECTIVE EFFECT IN CONDITIONS OF EXPERIMENTAL DIABETES MELLITUS AND CEREBRAL BLOOD CIRCULATION DISORDER | 2015 |
|
RU2601622C1 |
| N-ACETYL-L-ASPARTIC ACID DISODIUM SALT SHOWING ANTIDEPRESSANT AND NOOTROPIC ACTIVITY | 1998 |
|
RU2141943C1 |
